Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

mark cuban pharmacy benefits managers

Mark Cuban to CEOs: ‘If you’re using a Big 3 pharmacy benefits manager, you are getting ripped off. Period. End of story.’

The White House held a roundtable discussion on lowering healthcare costs last week. Fortune magazine followed up with one of the panelists, business mogul and Cost Plus Drugs cofounder Mark Cuban.

March 11, 2024
hospital price transparency

Transparency report called ‘irresponsible,’ ‘reckless’

Have hospitals really taken a step backward along their march toward price transparency? Or is the watchdog outfit making the claim playing fast and loose with the facts?

March 11, 2024
Weekly doses of semaglutide, a GLP-1 receptor originally developed to treat diabetes, could help approximately 93 million U.S. adults lose weight and reduce their risk of adverse cardiovascular events, according to new research published in Cardiovascular Drugs and Therapy. Novo Nordisk sells and markets subcutaneous treatments of semaglutide 2.4 mg under the brand name Wegovy.

A big win for Wegovy: Weight loss drug semaglutide first in history to gain FDA approval for reducing heart risks

The FDA made a special announcement about its decision, describing the news as "a major advance for public health."

March 8, 2024
change healthcare cyberattack

Change Healthcare cyberattack: A recap and update in 10 quotes

“This is what happens when everything merges and you only have one option.”

March 8, 2024
Patients who take diuretics, renin-angiotensin system (RAD) inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs) at the same time face a much higher risk of developing acute kidney injury (AKI)

Some older patients taking aspirin to prevent CVD may be doing more harm than good

“Aspirin is no longer a one-size-fits-all preventive tool for older adults," according to one specialist with Michigan Medicine. 

March 7, 2024
The rapid rise of artificial intelligence (AI) has helped cardiologists, radiologists, nurses and other healthcare providers embrace precision medicine in a way that ensures more heart patients are receiving personalized care.

AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do

A new scientific statement from the American Heart Association explores the many ways AI and machine learning are being used to improve care for heart patients.

March 7, 2024
Product Recall

FDA announces new Class I recall of drainage systems after 26 injuries

According to the agency, using these devices “may cause serious injuries or death.”

March 7, 2024
Dexcom, a global healthcare technology company based out of San Diego, has received the first over-the-counter U.S. Food and Drug Administration (FDA) clearance for a wearable glucose biosensor that can be obtained without a prescription, the Stelo..

FDA clears first over-the-counter wearable device for continuous glucose monitoring

The newly cleared device is worn on the back of the arm and sends data directly to the user's smartphone. 

March 6, 2024